Abstract:The present study investigated the mechanism underlying Toll-like receptor 4 (TLR4)-mediated stimulation of hypoxia-inducible factor-1 (HIF-1) activity and its association with reactive oxygen species (ROS) in cervical cancer cells. SiHa cells were cultured and randomized to control, lipopolysaccharide (LPS), methyl-beta-cyclodextrin (MCD)+LPS, ammonium pyrrolidinedithiocarbamate (PDTC)+LPS, ST2825+LPS and small interfering (si) RNA TLR4+LPS treatment groups. Cell proliferation was quantified using an MTT assay, cell cloning was performed using soft agar colony formation and HIF-1 alpha expression was detected by immunocytochemical staining and western blot analyses. Dichloro-dihydro-fluorescein diacetate and lucigenin luminescence assays were used to detect alterations in ROS and nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase content, respectively. Co-localization of TLR4 and HIF-1 alpha was detected by immunofluorescence staining and observed using fluorescence microscopy. Compared with the control group, cell proliferation was enhanced in the LPS-treated group and was not altered in the PDTC+LPS treatment group. Cell proliferation was reduced in all other treatment groups (P<0.05). Compared with the LPS group, cell proliferation decreased in all other groups. Compared with the PDTC+LPS treatment group, cell proliferation significantly decreased when LPS was co-administered with ST2825, siTLR4 and M beta CD (P<0.01). Treatment with M beta CD+LPS exhibited an increased inhibitory effect on cell activity and proliferation. Compared with the control group, HIF-1 alpha expression was enhanced following treatment with LPS, although it decreased when LPS was co-administered with ST2825, siTLR4 and M beta CD (P<0.05). HIF-1 alpha expression decreased following treatment with ST2825, siTLR4, M beta CD and PDTC+LPS, compared with treatment with LPS alone. Compared with the PDTC+LPS group, HIF-1 alpha activity decreased when LPS was co-administered with ST2825, siTLR4 and M beta CD. NADPH oxidase and ROS levels increased in cells treated with LPS, compared with the control group, at 24 and 12 h following treatment, respectively, and decreased at 12 h when LPS was co-administered with ST2825, siTLR4 and M beta CD. There was no difference between the LPS and PDTC+LPS groups with respect to NADPH and ROS levels. Compared with the PDTC+LPS group, NADPH oxidase activity and ROS content decreased when LPS was co-administered with ST2825, siTLR4 and M beta CD. NADPH oxidase activity and ROS content were lowest in the M beta CD+LPS treatment group, and immunofluorescent staining demonstrated that TLR4 was localized to the cell surface and HIF-1 alpha was primarily localized to the cytoplasm. TLR4 was co-expressed with HIF-1 alpha in cervical cancer cells. The results of the present study suggested that TLR4 signaling primarily promoted HIF-1 alpha activity via activation of lipid rafts/NADPH oxidase redox signaling and may be associated with the initiation and progression of cervical cancer. This promoting effect was stronger in TLR4/lipid rafts/NADPH oxidase pathway than that in TLR4-NF-kappa B signaling pathway. Therefore, the TLR4/lipid raft-associated redox signal may be a target for therapeutic intervention to prevent the growth of cervical cancer.

Hypoxia-inducible Factor-1 Up-Regulates the Expression of Toll-like Receptor 4 in Pancreatic Cancer Cells under Hypoxic Conditions

TLR4 Signaling Promotes Immune Escape of Human Lung Cancer Cells by Inducing Immunosuppressive Cytokines and Apoptosis Resistance.

Effcet of Silencing HIF-1α by Sirna on Expression of Toll-Like Receptor 4 in Pancreatic Cancer Cells under Hypoxic Conditions

Expression and Significance of TLR4 and HIF-1α in Pancreatic Ductal Adenocarcinoma

Expression and Significance of TLR9 and HIF-1α in Pancreatic Cancer

Endogenously Expressed IL-4Rα Promotes the Malignant Phenotype of Human Pancreatic Cancer in Vitro and in Vivo

TLR4 Promotes the Expression of HIF-1α by Triggering Reactive Oxygen Species in Cervical Cancer Cells Inï¿½vitro-Implications for Therapeutic Intervention

Expression and Significance of TLR2 and HIF-1α in Pancreatic Cancer

The role of HIF-1α and NF-κB pathways in hypoxia adjustment of pancreatic carcinoma and tumor progression

Tlr4 Promotes The Expression Of Hif-1 Alpha By Triggering Reactive Oxygen Species In Cervical Cancer Cells In Vitro-Implications For Therapeutic Intervention

The Role of Toll-Like Receptors (tlrs) in Pan-Cancer

HIF-1α links β-adrenoceptor agonists and pancreatic cancer cells under normoxic condition

Retraction Note To: the Hypoxia-Inducible Factor-1 Regulates the Microrna185 Expression Through Binding to Hypoxia Response Elements Sequence 2

High Glucose-Upregulated PD-L1 Expression Through RAS Signaling-Driven Downregulation of PTRH1 Leads to Suppression of T Cell Cytotoxic Function in Tumor Environment

Hypoxia-inducible Factor-1Α Regulates Chemotactic Migration of Pancreatic Ductal Adenocarcinoma Cells Through Directly Transactivating the CX3CR1 Gene.

Hypoxia Inducible Factor (Hif)-1Α Directly Activates Leptin Receptor (Ob-R) in Pancreatic Cancer Cells.

STIM1 Overexpression in Hypoxia Microenvironment Contributes to Pancreatic Carcinoma Progression

Expression and correlation of Hypoxia inducible Factor 1α and drug-resistance-correlated proteins in human pancreatic carcinoma

Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer

HTF4 modulates the transcription of GID2 to promote the malignant biological behavior of pancreatic cancer

[Expression of Hypoxia Inducible Factor-1Α and Insulin in Pancreatic Cancer and Their Correlation].